GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medizen Humancare Inc Co Ltd (XKRX:236340) » Definitions » Beneish M-Score

Medizen Humancare Co (XKRX:236340) Beneish M-Score : -3.50 (As of Sep. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Medizen Humancare Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.5 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Medizen Humancare Co's Beneish M-Score or its related term are showing as below:

XKRX:236340' s Beneish M-Score Range Over the Past 10 Years
Min: -4.24   Med: -3.5   Max: -2.02
Current: -3.5

During the past 7 years, the highest Beneish M-Score of Medizen Humancare Co was -2.02. The lowest was -4.24. And the median was -3.50.


Medizen Humancare Co Beneish M-Score Historical Data

The historical data trend for Medizen Humancare Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medizen Humancare Co Beneish M-Score Chart

Medizen Humancare Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial -4.24 -2.86 -3.76 -2.02 -3.50

Medizen Humancare Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score Get a 7-Day Free Trial -4.24 -2.86 -3.76 -2.02 -3.50

Competitive Comparison of Medizen Humancare Co's Beneish M-Score

For the Diagnostics & Research subindustry, Medizen Humancare Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medizen Humancare Co's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medizen Humancare Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medizen Humancare Co's Beneish M-Score falls into.



Medizen Humancare Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medizen Humancare Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9174+0.528 * 1.0079+0.404 * 0.7682+0.892 * 1.1583+0.115 * 0.8073
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.928+4.679 * -0.217976-0.327 * 0.9113
=-3.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was ₩1,804 Mil.
Revenue was ₩4,575 Mil.
Gross Profit was ₩981 Mil.
Total Current Assets was ₩3,002 Mil.
Total Assets was ₩4,239 Mil.
Property, Plant and Equipment(Net PPE) was ₩726 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩502 Mil.
Selling, General, & Admin. Expense(SGA) was ₩827 Mil.
Total Current Liabilities was ₩3,073 Mil.
Long-Term Debt & Capital Lease Obligation was ₩189 Mil.
Net Income was ₩-1,825 Mil.
Gross Profit was ₩0 Mil.
Cash Flow from Operations was ₩-901 Mil.
Total Receivables was ₩1,698 Mil.
Revenue was ₩3,950 Mil.
Gross Profit was ₩853 Mil.
Total Current Assets was ₩3,368 Mil.
Total Assets was ₩5,272 Mil.
Property, Plant and Equipment(Net PPE) was ₩1,076 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩530 Mil.
Selling, General, & Admin. Expense(SGA) was ₩770 Mil.
Total Current Liabilities was ₩4,040 Mil.
Long-Term Debt & Capital Lease Obligation was ₩412 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1803.942 / 4575.018) / (1697.537 / 3949.759)
=0.394303 / 0.429782
=0.9174

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(853.222 / 3949.759) / (980.558 / 4575.018)
=0.216019 / 0.214329
=1.0079

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3001.522 + 726.295) / 4239.176) / (1 - (3367.876 + 1076.377) / 5272.047)
=0.120627 / 0.157016
=0.7682

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4575.018 / 3949.759
=1.1583

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(530.238 / (530.238 + 1076.377)) / (502.272 / (502.272 + 726.295))
=0.330034 / 0.408828
=0.8073

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(827.31 / 4575.018) / (769.697 / 3949.759)
=0.180832 / 0.194872
=0.928

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((189.411 + 3072.916) / 4239.176) / ((412.081 + 4040.217) / 5272.047)
=0.769566 / 0.84451
=0.9113

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1825.374 - 0 - -901.334) / 4239.176
=-0.217976

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medizen Humancare Co has a M-score of -3.50 suggests that the company is unlikely to be a manipulator.


Medizen Humancare Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Medizen Humancare Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Medizen Humancare Co Business Description

Traded in Other Exchanges
N/A
Address
Republic of Korea 223, Teheran-ro, Gangnam-gu, Seoul, KOR
Medizen Humancare Inc Co Ltd is a R&D company providing genomics involving acquisition of disease specific genome contents, identification of new drug candidate genes and development of new preventive measures.

Medizen Humancare Co Headlines

No Headlines